NSE filing, NSE: RNPL. Summary written from the filing by ALFA Finder's alert engine.
Renol Polychem Ltd: key numbers
- Share price
- ₹59.60
- Market cap
- ₹72.02 Cr
- Revenue (annual)
- ₹89.99 Cr
- Net profit (annual)
- ₹8.25 Cr
- P/E (TTM)
- 8.7×Sector 34.1×
- Promoter holding
- 51.10%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Renol Polychem Ltd
All →Renol Polychem Other Announcement
Renol Polychem Limited has filed a routine compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Renol Polychem Annual General Meeting
Renol Polychem Limited held its 3rd Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary and special business.
Renol Polychem Board Meeting Outcome
Renol Polychem Limited announced the outcome of its board meeting held on September 07, 2026, approving the AGM notice and various auditor appointments for upcoming years.
Renol Polychem Annual General Meeting
Renol Polychem Limited has issued a notice for its 3rd Annual General Meeting, scheduled for September 30, 2026. Shareholders will consider various routine and special business items.
Renol Polychem H2 FY26 Results: Net Profit ₹5.9 Cr, Up 110.7% YoY
Renol Polychem Ltd reported revenue from operations of ₹49.9 Cr (+49.4% YoY) and net profit of ₹5.9 Cr (+110.7% YoY) for H2 FY26.
- Key figure
- Net profit ₹5.9 Cr · +110.7% YoY
Renol Polychem Financial Results
Renol Polychem Limited reported its audited consolidated financial results for the year ended March 31, 2026. The board also reviewed statutory auditor reports and fund utilization statements.
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.